| [1] |
Lv P, Yang J, Wang J, et al. Ischemic stroke prediction of patients with carotid atherosclerotic stenosis via multi-modality fused network[J]. Front Neurosci, 2023, 17(1):1118376. doi:10.3389/fnins.2023.1118376.
|
| [2] |
Navarro J C, Pedregosa B C, Sarfati M S F, et al. Standardising the diagnosis and imaging of intracranial atherosclerotic stenosis in Asia:a call for regional consensus[J]. Stroke Vasc Neurol, 2026, 11(3):286-288. doi:10.1136/svn-2025-004683.
|
| [3] |
Li X, Zhang M, Chen A, et al. Lipoic acid nanoparticles exert effective antiatherosclerosis effects through anti-inflammatory and antioxidant pathways[J]. ACS Omega, 2024, 9(49):48642-48649. doi:10.1021/acsomega.4c07745.
|
| [4] |
贾建普, 王丽轩, 赵泽宇, 等. 颅内动脉粥样硬化性狭窄患者血清ox-LDL,RC和NLR联合检测对临床预后的预测价值[J]. 现代检验医学杂志, 2025, 40(2):104-108.
|
|
Jia J P, Wang L X, Zhao Z Y, et al. Prognostic value of combined serum ox-LDL,RC and NLR tests for clinical prognosis in patients with intracranial atherosclerotic stenosis[J]. J Mod Lab Med, 2025, 40(2):104-108. doi:10.3969/j.issn.1671-7414.2025.02.019.
|
| [5] |
周明, 汪家文, 路艳林, 等. SDF-1/CXCR4轴通过NF-κB信号通路调控炎症反应减轻动脉粥样硬化的形成[J]. 重庆医科大学学报, 2025, 50(2):237-243.
|
|
Zhou M, Wang J W, Lu Y L, et al. SDF-1/CXCR4 axis regulates inflammatory responses to attenuate atherosclerosis via the NF-κB signaling pathway[J]. J Chongqing Med Univ, 2025, 50(2):237-243. doi:10.13406/j.cnki.cyxb.003655.
|
| [6] |
申晓平, 魏依兰, 白磊鹏, 等. 脑梗死患者血清血管生成素样蛋白8水平与颅内动脉粥样硬化狭窄程度的相关性研究[J]. 心肺血管病杂志, 2020, 39(7):812-816.
|
|
Shen X P, Wei Y L, Bai L P, et al. Correlation between serum angiopoietin like-8 levels and intracranial artery atherosclerotic stenosis in patients with cerebral infarction[J]. Journal of Cardiovascular & Pulmonary Diseases, 2020, 39(7):812-816. doi:10.3969/j.issn.1007-5062.2020.07.014.
|
| [7] |
中国研究型医院学会, 中国医师协会神经介入专业委员会, 中国神经科学学会脑血管功能与疾病分会, 等. 颅内动脉粥样硬化性狭窄诊治指南(2025版)[J]. 中华医学杂志, 2025, 105(29):2449-2468.
|
|
Chinese Research Hospital Association, Neurointerventional Professional Committee of Chinese Medical Doctor Association, Branch of Cerebrovascular Function & Disease of the Chinese Neuroscience Society, et al. Guidelines for diagnosis and treatment of intracranial atherosclerotic stenosis (2025 edition)[J]. Natl Med J China, 2025, 105(29):2449-2468. doi:10.3760/cma.j.cn112137-20250401-00785.
|
| [8] |
Shang Y, Dai H, Dai D, et al. Secondary structure changes of ox-LDL by photoirradiation in an optofluidic resonator[J]. Chin Opt Lett, 2022, 20(3):031702. doi:10.3788/COL202220.031702.
|
| [9] |
Zhang H, Fan L J, Liu J, et al. Safflor yellow A protects vascular endothelial cells from ox-LDL-mediated damage[J]. J Recept Signal Transduct Res, 2022, 42(1):52-59. doi:10.1080/10799893.2020.1843492.
|
| [10] |
Wang H, Hu H, Ma J, et al. lncRNA ZFAS1 promotes the ox-LDL induced proliferation,invasion and migration of vascular smooth muscle cells[J]. Exp Ther Med, 2021, 22(2):835-839. doi:10.3892/etm.2021.10267.
|
| [11] |
Han R, Luo J, Wang L, et al. miR-33a-5p suppresses ox-LDL-stimulated calcification of vascular smooth muscle cells by targeting METTL3[J]. Cardiovasc Toxicol, 2021, 21(9):737-746. doi:10.1007/s12012-021-09663-0.
|
| [12] |
Murad H A S, Rafeeq M M, Alqurashi T M A. Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis:still a debate[J]. Ann Med, 2021, 53(1):1598-1612. doi:10.1080/07853890.2021.1974084.
|
| [13] |
Bao S, Darvishi M, Hamin A, et al. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment[J]. J Cancer Res Clin Oncol, 2023, 149(10):7945-7968. doi:10.1007/s00432-022-04444-w.
|
| [14] |
Wang Q, Meng L, Xu R, et al. Relationship between CXCR4 and GNG4 in the brain and chronic stress-induced atherosclerosis[J]. J Mol Med(Berl), 2025, 103(9):1113-1134. doi:10.1007/s00109-025-02572-7.
|
| [15] |
Chen G, Wang X, Jin Z, et al. HIF-1α knockdown attenuates inflammation and oxidative stress in ischemic stroke male rats via CXCR4/NF-κB pathway[J]. Brain Behav, 2024, 14(9):e70039. doi:10.1002/brb3.70039.
|
| [16] |
Chai H, Qu H, He S, et al. Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway[J]. Pharmacol Res, 2022, 182:106328. doi:10.1016/j.phrs.2022.106328.
|
| [17] |
Mohammedsaeed W, Binjawhar D. The correlations between angiopoietin like 8 and cardiometabolic risk factors in Saudi women with type 2 diabetes mellitus:A pilot study[J]. Diab Vasc Dis Res, 2024, 21(3):1-6. doi:10.1177/14791641241259792.
|
| [18] |
Jiao X, Yang Y, Li L, et al. Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE-/- mice[J]. Atherosclerosis, 2020, 307(1):63-71. doi:10.1016/j.atherosclerosis.2020.06.014.
|
| [19] |
Liu Y Z, Zhang C, Jiang J F, et al. Angiopoietin-like proteins in atherosclerosis[J]. Clin Chim Acta, 2021, 521(1):19-24. doi:10.1016/j.cca.2021.06.024.
|
| [20] |
胡明哲, 陈香岩, 吴光亮, 等. 中性粒细胞淋巴细胞比值、淋巴细胞单核细胞比值与症状性颅内动脉粥样硬化性狭窄的关系[J]. 天津医药, 2022, 50(5):493-497.
|
|
Hu M Z, Chen X Y, Wu G L, et al. Research on the correlation between neutrophil lymphocyte ratio,lymphocyte monocyte ratio and symptomatic intracranial atherosclerotic stenosis[J]. Tianjin Med J, 2022, 50(5):493-497. doi:10.11958/20212251.
|